A blood stem cell transplant in a person with concomitant Hodkin disease and testicular carcinoma

Bone Marrow Transplantation

Volumn 19, Issue 8, 1997, Pages 857-858

  Varterasian, M L ^a,b   Aref, A ^a   Karanes, C ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Blood stem cell transplant; Concomitant; Hodgkin disease; Testicular carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CHLORMETHINE; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; HODGKIN DISEASE; HUMAN; MALE; PRIORITY JOURNAL; REMISSION; STEM CELL TRANSPLANTATION; TESTIS CARCINOMA;

EID: 0030965313     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700741     Document Type: Article

References (7)

1. Dexeus FH, Logothetis CJ, Kilbourn R et al. Association of germ cell tumors and Hodgkin's disease. Urology 1991; 37: 129-134.
2. Gerl A, Clemm C, Salat C et al. Testicular cancer and Hodgkin disease in the same patient. Cancer 1993; 71: 2838-2840.
3. Reece DE, Barnett MJ, Connors JM et al. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 1991; 9: 1871-1879.
4. Jones RJ, Piantadosi S, Mann RB et al. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 1990; 8: 527-537.
5. Chopra R, McMillan AK, Linen DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center 8-year study of 155 patients. Blood 1993; 81: 1137-1145.
6. Motzer RJ, Mazumdar M, Bosl GJ et al. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol 1996; 14: 1098-1105.
7. Siegert W, Beyer J, Strohscheer I et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol 1994; 12. 1223-1231.